A novel standard to evaluate the impact of therapeutic agents on patient safety – The BURDEN OF THERAPY™©∗
Purpose: Currently, treatment-emergent adverse events (TEAEs) during a clinical study are summarized over the entire study period. Objective: Develop and validate a novel methodology, BURDEN OF THERAPY©∗ (BOTh©∗), to quantify presence and severity of TEAEs on each day of study. Methods: BOTh utilize...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-12-01
|
Series: | Contemporary Clinical Trials Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451865416300400 |